Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Terns Pharmaceuticals (TERN) Loans and Notes Receivables (2020)

Terns Pharmaceuticals filings provide 1 years of Loans and Notes Receivables readings, the most recent being $12.7 million for Q4 2020.

  • Quarterly Loans and Notes Receivables changed N/A to $12.7 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $12.7 million through Dec 2020, changed N/A year-over-year, with the annual reading at $12.7 million for FY2020, N/A changed from the prior year.
  • Loans and Notes Receivables hit $12.7 million in Q4 2020 for Terns Pharmaceuticals.
  • Across five years, Loans and Notes Receivables topped out at $12.7 million in Q4 2020 and bottomed at $12.7 million in Q4 2020.